Rani Therapeutics Ownership | Who Owns Rani Therapeutics?

Overview Forecast RevenueFinancials Chart Transcripts

Rani Therapeutics Ownership Summary

Rani Therapeutics is owned by 11.11% institutional investors, 30.61% insiders, and 58.27% retail investors. Vanguard group is the largest institutional shareholder, holding 2.73% of RANI shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 1.60% of its assets in Rani Therapeutics shares.

RANI Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Rani Therapeutics	11.11%	30.61%	58.27%
Sector	Healthcare Stocks	47.31%	8.01%	44.69%
Industry	Biotech Stocks	45.43%	7.81%	46.75%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Vanguard group	709.83K	2.73%	$2.70M
Nan fung group	493.58K	1.90%	$1.88M
Alphabet	448.49K	1.72%	$1.70M
United services automobile association	312.10K	1.20%	$1.19M
Geode capital management	150.73K	0.58%	$572.92K
Stifel financial	134.62K	0.52%	$511.56K
Bank of america corp /de/	91.85K	0.35%	$349.01K
Bridgeway capital management	71.50K	0.27%	$271.70K
Blackrock	63.58K	0.24%	$241.62K
Lasry marc	62.89K	0.24%	$238.97K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Nan fung group	493.58K	2.00%	$1.88M
Lasry marc	62.89K	0.24%	$238.97K
Alphabet	448.49K	0.09%	$1.70M
United services automobile association	312.10K	0.03%	$1.19M
Islay capital management	9.61K	0.03%	$36.52K
Lafayette investments	19.89K	0.02%	$75.59K
Motco	48.13K	0.01%	$182.89K
Bridgeway capital management	71.50K	0.01%	$271.70K
Virtu financial	10.15K	0.00%	$39.00K
King luther capital management	56.13K	0.00%	$213.29K

Top Buyers

Holder	Shares	% Assets	Change
Vanguard group	709.83K	0.00%	24.52K
Bridgeway capital management	71.50K	0.01%	20.00K
Geode capital management	150.73K	0.00%	19.83K
Tower research capital llc (trc)	14.44K	0.00%	13.20K
Virtu financial	10.15K	0.00%	10.15K

Top Sellers

Holder	Shares	% Assets	Change
United services automobile association	312.10K	0.03%	-169.21K
Renaissance	21.70K	0.00%	-48.60K
Alpha square group s	-	-	-33.40K
Bank of america corp /de/	91.85K	-	-32.66K
Xr securities	-	-	-30.90K

New Positions

Holder	Shares	% Assets	Change	Value
Virtu financial	10.15K	0.00%	10.15K	$39.00K

Sold Out

Holder	Change
Qube research	-3.00
Wells fargo & company/mn	-103.00
Belvedere trading	-991.00
Activest wealth management	-9.80K
Choreo	-19.81K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2024	36	-2.70%	2,893,303	-7.12%	11	7.45%	12	-	7	40.00%
Mar 31, 2024	37	15.63%	3,115,105	5.54%	12	9.15%	12	140.00%	5	-16.67%
Dec 31, 2023	32	-3.03%	2,951,624	-8.01%	11	7.21%	5	-44.44%	6	-14.29%
Sep 30, 2023	33	-8.33%	3,208,534	-0.58%	12	7.74%	9	-43.75%	7	250.00%
Jun 30, 2023	36	-2.70%	3,227,286	7.60%	12	9.05%	16	6.67%	2	-50.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	518.70K	1.60%	-
Vanguard Institutional Extnd Mkt Idx Tr	172.98K	0.53%	-
Tema Obesity & Cardiometabolic ETF	105.60K	0.33%	-
Fidelity Extended Market Index	90.84K	0.28%	15.26K
Bridgeway Ultra-Small Company Market	71.50K	0.24%	20.00K
Northern Small Cap Core I	23.70K	0.08%	23.70K
Fidelity Total Market Index	26.25K	0.08%	-
Fidelity Series Total Market Index	21.01K	0.06%	4.01K
BlackRock Extended Equity Market K	16.40K	0.06%	-7.00
NT Ext Equity Mkt Idx Fd - L	16.26K	0.06%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Oct 15, 2024	South Cone Investments Limited Partnership	-	Sell	$1.71M
Oct 15, 2024	South Cone Investments Limited Partnership	-	Sell	$8.44M
Nov 24, 2023	Quiroga Cortes Isidoro Alfonso	-	Sell	$10.58M
Nov 24, 2023	South Cone Investments Limited Partnership	-	Buy	$10.58M
Dec 06, 2023	Imran Talat	Chief Executive Officer	Buy	$22.70K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	2
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	8	1
2023 Q3	-	-

RANI Ownership FAQ

Who Owns Rani Therapeutics?

Rani Therapeutics shareholders are primarily institutional investors at 11.11%, followed by 30.61% insiders and 58.28% retail investors. The average institutional ownership in Rani Therapeutics's industry, Biotech Stocks , is 45.43%, which Rani Therapeutics falls below.

Who owns the most shares of Rani Therapeutics?

Rani Therapeutics’s largest shareholders are Vanguard group (709.83K shares, 2.73%), Nan fung group (493.58K shares, 1.90%), and Alphabet (448.49K shares, 1.72%). Together, they hold 6.35% of Rani Therapeutics’s total shares outstanding.

Does Blackrock own Rani Therapeutics?

Yes, BlackRock owns 0.24% of Rani Therapeutics, totaling 63.58K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 241.62K$. In the last quarter, BlackRock decreased its holdings by 0 shares, a 0% change.

Who is Rani Therapeutics’s biggest shareholder by percentage of total assets invested?

Nan fung group is Rani Therapeutics’s biggest shareholder by percentage of total assets invested, with 2.00% of its assets in 493.58K Rani Therapeutics shares, valued at 1.88M$.

Who is the top mutual fund holder of Rani Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Rani Therapeutics shares, with 1.60% of its total shares outstanding invested in 518.7K Rani Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools